Ignite Creation Date:
2024-05-06 @ 10:29 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03276624
Status:
UNKNOWN
Last Update Posted:
2017-09-08
First Post:
2017-09-04
Brief Title:
Early Outcome in Unstable Angina Patients With Low EF After CABG
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Early Outcome in Chronic Unstable Angina Patients With Low Ejection Fraction After CABG
Status:
UNKNOWN
Status Verified Date:
2017-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Coronary artery bypass grafting CABG among patients with reduced myocardial function remains a surgical challenge despite improvement in surgical technique myocardial protection and postoperative care Such cases are considered as high risk and associated with a higher peri-operative mortality than those with normal left ventricular function LVF Patients with low EF are at higher risks of sudden death ventricular arrhythmia and worsening heart failure due to recurrent ischemia Thereforeearly recognition of patients at risk for a worse outcome plays a pivotal role in the decision making process allowing the prompt institution of an adequate support
Detailed Description:
Current treatment options for Chronic Unstable Angina patients with low Ejection Fraction include intensive medical therapy surgical revascularization ventricular remodeling and heart transplantation Medical treatment alone is problematic because of limited long-term survival Heart transplantation offers excellent results with a 656 5-year survival rate however the scarcity of donor organs the need for lifelong immunosuppression and the fact that heart transplantation has been restricted to those without co-morbid medical conditions and relatively restricted to those younger than 65 years of age makes this option impractical for a majority of patients As a result coronary artery bypass graft CABG surgery is the optimal therapeutic approach and remains superior to medical therapy Numerous controlled trials of coronary artery bypass grafting in patients with low left ventricular ejection fraction LVEF have shown that these are the patients that benefit most from revascularization especially if symptoms of angina or ischemia are present This benefit is not only for symptoms but also on longevity It is believed that the most important factor for successful surgical recovery may be the viability of revascularized myocardium
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None